Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease.

Expert Opinion on Drug Metabolism & Toxicology
Ramón Cacabelos

Abstract

Cholinergic dysfunction, demonstrated in the late 1970s and early 1980s, led to the introduction of acetylcholinesterase inhibitors (AChEIs) in 1993 (Tacrine) to enhance cholinergic neurotransmission as the first line of treatment against Alzheimer's disease (AD). The new generation of AChEIs, represented by Donepezil (1996), Galantamine (2001) and Rivastigmine (2002), is the only treatment for AD to date, together with Memantine (2003). AChEIs are not devoid of side-effects and their cost-effectiveness is limited. An option to optimize the correct use of AChEIs is the implementation of pharmacogenetics (PGx) in the clinical practice. (i) The cholinergic system in AD, (ii) principles of AD PGx, (iii) PGx of Donepezil, Galantamine, Rivastigmine, Huperzine and other treatments, and (iv) practical recommendations. The most relevant genes influencing AChEI efficacy and safety are APOE and CYPs. APOE-4 carriers are the worst responders to AChEIs. With the exception of Rivastigmine (UGT2B7, BCHE-K), the other AChEIs are primarily metabolized via CYP2D6, CYP3A4, and UGT enzymes, with involvement of ABC transporters and cholinergic genes (CHAT, ACHE, BCHE, SLC5A7, SLC18A3, CHRNA7) in most ethnic groups. Defective variants may affect th...Continue Reading

References

Sep 1, 1976·Brain : a Journal of Neurology·D M BowenA N Davison
Feb 1, 1978·Journal of Medical Genetics·H M RubinsteinT Lubrano
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H SoreqY Lipidot-Lifson
Nov 13, 1986·The New England Journal of Medicine·W K SummersA Kling
Apr 1, 1989·Lancet·W K SummersA Kling
May 1, 1980·Clinical Toxicology·W K SummersJ M Fischer
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·J PoirierS Gauthier
Jan 17, 1996·Annals of the New York Academy of Sciences·G BissetteT A Slotkin
Jun 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R J FontanaP B Watkins
Aug 1, 1997·Biochemical Pharmacology·M W Sinz, T F Woolf
Nov 5, 1997·Annals of the New York Academy of Sciences·L S Schneider, M Farlow
Jul 1, 1997·Neurobiology of Aging·S M EfangeD C Mash
Oct 20, 1998·International Journal of Geriatric Psychiatry·S H MacGowanM Scott
Feb 25, 1999·International Journal of Geriatric Psychiatry·R CacabelosB Winblad
May 9, 2000·Clinical Pharmacology and Therapeutics·T SimonP Jaillon
Jul 8, 2000·Metabolic Brain Disease·J K Blusztajn, B Berse
Jul 25, 2000·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A S RigaudF Boller
Oct 12, 2000·Biochemical and Biophysical Research Communications·S ApparsundaramR D Blakely
Feb 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·K OhnoA G Engel
Feb 15, 2001·Dementia and Geriatric Cognitive Disorders·J AerssensW Parys
Jul 28, 2001·Journal of Neural Transmission·M SjögrenK Blennow
Aug 15, 2001·Neurology·B WinbladUNKNOWN Donepezil Nordic Study Group
Apr 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·G S J MannensW Meuldermans
May 15, 2002·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Barbara BorroniAlessandro Padovani

❮ Previous
Next ❯

Citations

Jan 23, 2021·Pharmaceutics·Maria D AuxteroAna I Fernandes
Dec 12, 2020·Drug Discovery Today·Shvetank BhattChandragauda R Patil
Aug 1, 2021·Expert Opinion on Drug Discovery·Ramón CacabelosVinogran Naidoo
Feb 8, 2022·Expert Opinion on Drug Discovery·Ramón Cacabelos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Investigational Drugs
Daniela Galimberti, Elio Scarpini
Brain and nerve = Shinkei kenkyū no shinpo
Shunichiro Shinagawa, Masahiro Shigeta
Mini Reviews in Medicinal Chemistry
Hulya Akıncıoğlu, İlhami Gülçin
© 2022 Meta ULC. All rights reserved